The role of compounded mouthwash with or without acyclovir in managing chemotherapy-induced oral mucositis in cancer patients: a randomized controlled trial

This trial was approved by the Institutional Research Board (IRB) under the code R.23.05. 2176.R1. Date: 20 May 2023.

Authors

Institutions

Publication Details

Journal
BMC Oral Health
Published
2025-06-21
DOI
https://doi.org/10.1186/s12903-025-06324-4
Citations
1
Primary Topic
Oral health in cancer treatment
Type
article
Field-Weighted Citation Impact
1.52

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The role of compounded mouthwash with or without acyclovir in managing chemotherapy-induced oral mucositis in cancer patients: a randomized controlled trial

Shaimaa El‐Ashwah, Salma Elashwah, Mohamed Mabed, Azza Abdelnasser
1 citations
BMC Oral Health
Oral health in cancer treatment
1.52
article

The role of compounded mouthwash with or without acyclovir in managing chemotherapy-induced oral mucositis in cancer patients: a randomized controlled trial

Shaimaa El‐Ashwah, Salma Elashwah, Mohamed Mabed, Azza Abdelnasser
article en
1 citations

Abstract

This trial was approved by the Institutional Research Board (IRB) under the code R.23.05. 2176.R1. Date: 20 May 2023.

BMC Oral HealthVol. 25(1)
Mansoura University (EG)
Science and Technology Development Fund, Mansoura University
Good health and well-being
Openalex Percentile: Top 17%
Oral health in cancer treatment
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.